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Aim To determine the effects of hyoscine-N-butyl bromide 
(HBB) rectal suppository on labor progress in primigravid 
women.
Methods A randomized double-blind placebo-controlled 
clinical trial was carried out on 130 primigravid women ad-
mitted for spontaneous labor. The women were recruit-
ed based on the inclusion and exclusion criteria and ran-
domized into the experimental (n = 65) and control group 
(n = 65). In the beginning of the active phase of labor, 20 
mg of HBB rectal suppository was administered to the ex-
perimental group, while a placebo suppository was ad-
ministered to the control group. Cervical dilatation and 
duration of active phase and second stage of labor were 
recorded.
Results The rate of cervical dilatation was 2.6 cm/h in the 
experimental and 1.5 cm/h in the control group (P < 0.001). 
The active phase and the second stage of labor were sig-
nificantly shorter in the experimental group (P = 0.001 and 
P < 0.001, respectively). There was no significant difference 
between the two groups in the fetal heart rate, maternal 
pulse rate, blood pressure, and the APGAR score 1 and 5 
minutes after birth.
Conclusion Use of HBB rectal suppository in the active 
management of labor can shorten both the active phase 
and second stage of labor without significant side-effects.
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Active management of labor reduces the number of cesare-
an deliveries, the number of prolonged labors, and labor du-
ration, without having any adverse effects on the mother or 
the fetus (1-5). Spasmolytics, such as hyoscine -N-butyl bro-
mide (HBB), are commonly used during this process. Several 
studies, which included both primigravid and multigravid 
women, have shown that intravenous application of HBB 
(20-40 mg) during the active phase of labor increases cervi-
cal dilatation (6,7) and decreases duration of the first stage 
of labor (8-11). When given in the latent phase, during which 
the contractions are still not strong, HBB actually delays the 
labor progress by decreasing the intrauterine tension (8). 
Even though the rectal route is less invasive and would al-
low administration even by the patients themselves, effects 
of HBB given as a rectal suppository have been rarely stud-
ied. All of these studies involved both primigravid and mul-
tigravid women, which could be problematic in labor trials 
(9,10). In the study by Tiwari et al on 300 primigravid and 
multigravid women (11), 100 women received 20 mg of 
HBB intravenously, 100 women received 8 mg of valethe-
mate bromide every 20 minutes at 4 cm dilatation, and 100 
women received no drug. Significant shortening of the first 
stage of labor in primigravid women was noted in both ex-
perimental groups and it was more remarkable with HBB. 
In another study on the effect of intravenous HBB in the ac-
tive phase of labor (9), the mean time of the first stage in 
the experimental group was 31.7% shorter than in the con-
trol group. Gupta et al performed a prospective randomized 
trial on 150 women in active labor, 50 of whom were given 
drotaverine, 50 HBB, and 50 no medication (12). The mean 
duration of the active phase and the mean rate of cervical 
dilation did not differ between the groups.
The present study assessed the effects and safety of a sin-
gle dose (20 mg) of HBB administered as a rectal supposi-
tory during labor, since such administration of HBB has 
been demonstrated to be less invasive and simpler, even 
possible by the patient herself.
MeThodS
The study design was approved by the institutional Eth-
ics Committee of Ahvaz Jundishapur University of Medical 
Sciences and registered within the Iranian registry of clini-
cal trials (http://irct.ir); IRCT No.: IRCT138804282204N1. The 
trial was conducted at the Sina hospital in Ahvaz, Iran, be-
tween July and October 2009.
A preliminary power analysis was carried out to calcu-
late the sample size for the experimental and control 
groups using a formula recommended by previous stud-
ies: d = Δ/SD, where d is standardized difference, Δ is the 
smallest clinically significant difference, and SD is standard 
deviation of the test group. Duration of 60 minutes was 
considered as the smallest clinically significant difference, 
and the SD (68.9 minutes) was selected from the study per-
formed by Sirohiwal et al (10). Also, a standardized differ-
ence of 0.87 was obtained using nomogram (13). The pow-
er analysis suggested that a sample of 70 women in each 
group would provide a power of 95%, at 5% significance.
Participants
Women in labor were recruited from the antenatal clinic 
of our hospital after they had received information on the 
purpose and course of the study from the medical investi-
gator and had provided the written consent during routine 
visits. The trial included primigravid women between 18-
35 years of age with normal pregnancy, a singleton fetus 
at a gestational age of 37-42 weeks in a cephalic presen-
tation, and in the beginning of spontaneous labor. Since 
a number of studies reported a clear association between 
maternal overweight and dysfunction of active phase of 
labor, specifically arrest of dilatation (14,15), we included 
only women with a body mass index lower than 25 before 
pregnancy. The beginning of the active phase of labor was 
defined as cervical dilatation of 3-4 cm in the presence of 
moderate uterine contractions. Moderate uterine contrac-
tions were defined as those during which the underlying 
fetal parts were not palpable, but fingers could still be in-
dented in the abdominal wall. Exclusion criteria were ma-
ternal tachycardia (>100 bpm), antepartum hemorrhage, 
prolonged rupture of membranes, previous uterine scar, 
cephalopelvic disproportion, augmentation of labor using 
oxytocin, preeclampsia, heart disease, or any other serious 
medical conditions.
Intervention
Suppositories containing 20 mg HBB (courtesy of Exir phar-
maceuticals, Boroujerd, Iran) were prepared by a pharma-
ceutical technician who was not included the clinical tri-
al, as were the placebo suppositories, which consisted of 
a Suppocire AM-15, a semi-synthetic fatty acid glyceride 
(courtesy of Gattefosse, Lyon, France). The suppositories 
were held refrigerated until the time of their usage. Using 
a  block  randomization  method  (block  size = 4),  random 
numbers were assigned to each package. The patients and 
the medical investigator were not familiar with the content 
of each package. The participants were given one of the 161 Makvandi et al: Effects of HBB rectal suppository on labor progress in primigravid women
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rectal suppositories in the beginning of the active phase 
of labor.
outcome measures
Obstetric  examinations  and  routine  investigations  were 
carried out in all cases by a single investigator. According 
to the standard procedure at our institute, vaginal exami-
nation was performed every 2 hours to assess the progress 
of labor. Routine amniotomy was performed for women 
who did not have a spontaneous rupture of membranes at 
the time when the presenting part of the fetus was fixed. A 
partogram was maintained throughout the labor. Duration 
of the active phase of labor, rate of cervical dilatation, and 
duration of the second stage of labor were recorded.
Neonatal APGAR scores were determined 1 and 5 minutes 
after birth. Fetal heart rate, as well as the patient’s pulse 
rate and blood pressure were recorded every half an hour. 
Following  the  RANZCOG  intrapartum  fetal  surveillance 
clinical guidelines, fetal monitoring was done by intermit-
tent auscultation using Doppler ultrasound at least every 
15-30 minutes in the active phase of the first stage of labor 
and every 5 minutes in the second stage in the absence of 
active pushing, as well as after each contraction with ac-
tive pushing in the second stage (16). In the presence of 
risk factors for fetal compromise such as abnormal auscul-
tation, a continuous electronic fetal monitoring was used.
Statistical analysis
Data were analyzed with SPSS, version 15.0 (2006, SPSS Inc., 
Chicago IL, USA). Absolute and relative frequencies of cate-
gorical variables and mean and standard deviation of con-
tinuous  variables  were  calculated.  Continuous  variables 
were analyzed by t test, and χ2 test was used for categorical 
variables. When the χ2 test could not be applied for cate-
gorical variables, such as the first minute APGAR score, we 
used Fisher exact test.
ReSulTS
Participants’ flow through the study is shown in Figure 1. 
There was no significant difference in maternal character-
istics between the experimental and control group (Table 
1). The mean duration of the active phase of labor was 
141.0 ± 81.7-minute in the experimental and 230.1 ± 169.6-
minute in the control group (P = 0.001). The mean duration 
of the second stage of labor was 38.8 ± 24.3-minute in the 
experimental and 51.7 ± 23.8-minute in the control group 
(P < 0.001). The  rate  of  cervical  dilatation  was  2.6  cm/h 
in the experimental and 1.5 cm/h in the control group 
(P < 0.001).
There was no significant difference in the rate of cesarean 
section between the groups (7.69% vs 9.23%; P > 0.05). The 
most common indication for a cesarean section was an ar-
rest of dilatation, followed by thick meconium and placental 
abruption. There were no instrumental vaginal deliveries.
Figure 1.
Flow of participants through the study on the effect of hyoscine-N-butyl 
bromide rectal suppository on labor progress in primigravid women.
TAble 1. Characteristics of women in the experimental group who received hyoscine-N-butyl bromide suppository and women in 
the control group who received placebo suppository
Group (mean ± standard deviation or number, %)
Characteristic experimental (n = 65) control (n = 65) P
Age (year) 22.14 ± 3.72 22.38 ± 4.02 0.72
Body mass index before pregnancy (kg/m2) 23.34 ± 4.11 24.56 ± 5.78 0.52
Weight gain (kg) 13.14 ± 3.15 14.40 ± 3.84 0.48
Preterm rupture of membranes 25 (38.5) 25 (38.5) 1.00
Length of preterm rupture of membranes (h)   7.95 ± 1.89   8.41 ± 2.12 0.47
Cervical dilatation at intervention (cm)   3.83 ± 0.84   3.88 ± 0.71 0.74
Cervical effacement at intervention (%)* 64.15 ± 10.88 62.31 ± 9.81 0.31
*Thinning of the cervix as a percentage change from the baseline.CLINICAL SCIENCES 162 Croat Med J. 2011; 52: 159-63
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There was no significant difference in the fetal heart rate 
between the two groups (Table 2). Fetal heart rate varia-
tion  in  both  groups  was  7.7%  (3.10%  bradycardia  and 
4.60% tachycardia vs 4.60% bradycardia and 3.10% tachy-
cardia; P > 0.05).
There was no significant difference between the groups in 
the maternal pulse rate and mean systolic blood pressures 
either half an hour after the intervention (Table 2) or at oth-
er time intervals (P > 0.05) (data not shown).
Because of the shortening effect of spontaneous preterm 
rupture of membranes upon the first stage of labor (17), 
we did not find any significant difference between the 
groups in the number and duration of ruptures.
The drug was well tolerated by all patients and no adverse 
effect was noted. Out of 130 neonates, 2 in the experimen-
tal group had an APGAR score of 4-6, while the rest had a 
score of 8-10 one minute after birth. The APGAR score 5 
minutes after birth ranged from 8-10 in all 130 neonates.
dISCuSSIoN
The present study showed a significant decrease in labor 
duration when a 20 mg rectal suppository of HBB was used 
in the active phase of labor. Sirohiwal et al also found a 
significant difference in the duration of active phase of la-
bor between the control and study group (368.1 ± 133.0 vs 
123.9 ± 68.9 minute, respectively) (10), but the duration of 
second stage of labor was not affected. In our study, the 
second stage of labor was significantly shorter with HBB 
than with placebo. Although all women were encouraged 
to push at the beginning of the second stage of labor, 
the prolonged second stage could be related to the lon-
ger duration of the first stage of labor, which may have 
led to tiredness of the myometrium. On the other hand, 
Gupta et al found that the active phase duration and 
rate of cervical dilatation in the group that received 
HBB were not significantly different from the control group 
(12).  Similar  observations  were  also  made  by  Mortazavi 
and Rakhshani, who reported a longer first stage of labor 
with intramuscular HBB (18). We believe our results were 
influenced by the local effect of the rectal suppository on 
the cervical region, although the exact mechanism of ac-
tion is not established. It is possible that induced relaxation 
enables more effective myometrical contractions. Iravani 
and Bekhradinasab conducted a study using 20 mg in-
travenous  HBB  for  active  management  of  labor  in  100 
primigavid women with 100 primigavid women as con-
trol (7). They reported that 24% of fetuses in the experi-
mental group and 10% of fetuses in the control group had 
heart rate variation (8% bradycardia and 16% tachycardia 
vs 2% bradycardia and 8% tachycardia). Our study showed 
no such difference, so it is possible that these differences 
could be an effect of intravenous application of HBB which, 
in comparison with rectal suppository, can rapidly alter the 
fetal heart beat.
Although our study was not sufficiently powered to as-
sess adverse neonatal outcomes, the initial examination of 
each neonate, their APGAR score 1 and 5 minutes after the 
birth, showed no difference between the groups.
Since a primigravid woman can be fully dilated before she 
feels the pressure of giving birth, it is impossible to deter-
mine the exact time of the full cervical dilatation, although 
average time from administration of drug to delivery (total 
amount of active phase and second stage) was significant-
ly shorter in the experimental group.
We believe our study showed that HBB rectal suppository 
was effective in shortening the duration of labor. Further-
more, the rectal administration of the drug is more conve-
nient, absorption is faster, gastric irritation is avoided, and 
hepatic metabolism is partially bypassed (10). Further stud-
ies are necessary to fully evaluate the benefits of HBB, as 
well as its effect on women in induced labors or those with 
an active phase arrest or protraction disorders.
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(n = 65) P
fetal heart rate (per min) 140.87 ± 24.65 137.93 ± 26.61 0.51
maternal pulse rate (per min)   83.34 ± 10.56   86.65 ± 12.870.45
maternal systolic blood 
pressure (mmHg)
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